COVID-19 vaccines: the importance of transparency and fact-based education.
作者信息
Cohen Adam F, van Gerven Joop, Burgos Juan Garcia, de Boer Anthonius, Foucher Ron A M, Flore H, Teitelbaum Zvi, van Eden Willem, Webb Andrew, Cremers Serge
机构信息
Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
Central Committee for Human Research (CCMO) and Competent Trial Authority of The Netherlands, The Hague, The Netherlands.
出版信息
Br J Clin Pharmacol. 2020 Nov;86(11):2107-2110. doi: 10.1111/bcp.14581. Epub 2020 Oct 14.
Abstract
摘要
相似文献
1
COVID-19 vaccines: the importance of transparency and fact-based education.新冠疫苗：透明度和基于事实的教育的重要性。
Br J Clin Pharmacol. 2020 Nov;86(11):2107-2110. doi: 10.1111/bcp.14581. Epub 2020 Oct 14.
2
COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations.COVID-19 疫苗：免疫原性、安全性的现有认识及进一步的考虑因素。
Front Immunol. 2021 Apr 12;12:669339. doi: 10.3389/fimmu.2021.669339. eCollection 2021.
3
Communicating COVID-19 vaccines: lessons from the dengue vaccine controversy in the Philippines.传播新冠疫苗：菲律宾登革热疫苗争议的教训
BMJ Glob Health. 2021 Mar;6(3). doi: 10.1136/bmjgh-2021-005422.
4
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.异源初免-加强型新型冠状病毒肺炎疫苗接种：初始反应原性数据
Lancet. 2021 May 29;397(10289):2043-2046. doi: 10.1016/S0140-6736(21)01115-6. Epub 2021 May 12.
5
SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.儿童人群中的 SARS-CoV-2 疫苗试验和研究：生物学、伦理、研究和实施挑战。
Pediatr Res. 2021 Nov;90(5):966-970. doi: 10.1038/s41390-021-01402-z. Epub 2021 Feb 24.
6
Covid-19: Use social media to maximise vaccine confidence and uptake.新冠疫情：利用社交媒体最大限度地提高疫苗信心和接种率。
BMJ. 2021 Jan 26;372:n225. doi: 10.1136/bmj.n225.
7
Severe mental illness: reassessing COVID-19 vaccine priorities.严重精神疾病：重新评估新冠疫苗接种优先级
Lancet. 2021 Feb 20;397(10275):657. doi: 10.1016/S0140-6736(21)00429-3.
8
COVID-19 in Europe: new challenges for addressing vaccine hesitancy.欧洲的新冠疫情：应对疫苗犹豫问题的新挑战。
Lancet. 2022 Feb 19;399(10326):699-701. doi: 10.1016/S0140-6736(22)00150-7. Epub 2022 Feb 3.
9
Key populations for early COVID-19 immunization: preliminary guidance for policy.新冠病毒疾病早期免疫接种的重点人群：政策初步指南
CMAJ. 2020 Nov 30;192(48):E1620-E1632. doi: 10.1503/cmaj.202353. Epub 2020 Nov 3.
10
COVID-19 vaccines approved in the European Union: current evidence and perspectives.欧盟批准的新冠疫苗：当前证据与展望
Expert Rev Vaccines. 2021 Oct;20(10):1195-1199. doi: 10.1080/14760584.2021.1962304. Epub 2021 Aug 6.
引用本文的文献
1
Leveraging Ottawa Charter strategies to enhance COVID-19 vaccination: A systematic review of global health promotion approaches.利用渥太华宪章策略加强新冠疫苗接种：全球健康促进方法的系统评价
Health Promot Perspect. 2025 May 6;15(1):9-22. doi: 10.34172/hpp.025.43752. eCollection 2025 May.
2
Exploring the relationship between experience of vaccine adverse events and vaccine hesitancy: A scoping review.探索疫苗不良事件经历与疫苗犹豫之间的关系：一项范围综述。
Hum Vaccin Immunother. 2025 Dec;21(1):2471225. doi: 10.1080/21645515.2025.2471225. Epub 2025 Mar 9.
3
Exploring the relationship between vaccine hesitancy and mothers' perspectives on COVID-19 vaccines for children ages 5-11 years during the omicron predominant period 2021-2022: a qualitative study.探讨奥密克戎变异株流行期间（2021-2022 年），母亲对 5-11 岁儿童接种 COVID-19 疫苗的态度与疫苗犹豫之间的关系：一项定性研究。
Front Public Health. 2024 Jul 8;12:1355452. doi: 10.3389/fpubh.2024.1355452. eCollection 2024.
4
The impact of nontransparent health communication during the COVID-19 pandemic on vaccine-hesitant people's perception of vaccines.新冠大流行期间不透明的卫生沟通对疫苗犹豫者对疫苗的看法的影响。
Front Public Health. 2024 Jan 8;11:1256829. doi: 10.3389/fpubh.2023.1256829. eCollection 2023.
5
COVID-19 Vaccine for Children: Determinants and Beliefs Contributing to Vaccination Decision of Parents in Germany 2021/2022.儿童新冠疫苗：2021/2022年德国父母接种疫苗决定的影响因素与信念
Vaccines (Basel). 2023 Dec 23;12(1):20. doi: 10.3390/vaccines12010020.
6
Nephrotic syndrome following COVID-19 vaccination: a systematic review.接种 COVID-19 疫苗后的肾病综合征：系统评价。
J Nephrol. 2023 Dec;36(9):2431-2440. doi: 10.1007/s40620-023-01710-z. Epub 2023 Jul 28.
7
COVID-19 vaccinations: An overview of the Italian national health system's online communication from a citizen perspective.COVID-19 疫苗接种：从公民视角看意大利国家卫生系统的在线沟通概述。
Health Policy. 2022 Oct;126(10):970-979. doi: 10.1016/j.healthpol.2022.08.001. Epub 2022 Aug 4.
8
Assessing the knowledge and skill of vaccination staff at Adult Vaccination Counters for COVID-19 vaccines: Simulated client method.评估成人 COVID-19 疫苗接种点接种人员的疫苗接种知识和技能：模拟患者方法。
PLoS One. 2021 Dec 23;16(12):e0261286. doi: 10.1371/journal.pone.0261286. eCollection 2021.
9
Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust.透明地沟通 COVID-19 疫苗的负面特征会降低其接受度，但会增加信任。
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29). doi: 10.1073/pnas.2024597118. Epub 2021 Jul 2.
10
Effect of Information about COVID-19 Vaccine Effectiveness and Side Effects on Behavioural Intentions: Two Online Experiments.关于新冠疫苗有效性和副作用的信息对行为意图的影响：两项在线实验
Vaccines (Basel). 2021 Apr 13;9(4):379. doi: 10.3390/vaccines9040379.
本文引用的文献
1
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.评估 COVID-19 感染病死率的年龄特异性：系统评价、荟萃分析及公共政策意义。
Eur J Epidemiol. 2020 Dec;35(12):1123-1138. doi: 10.1007/s10654-020-00698-1. Epub 2020 Dec 8.
2
"When Will Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination.“何时会有疫苗？”——解读关于新冠疫苗接种的问答
N Engl J Med. 2020 Dec 3;383(23):2202-2204. doi: 10.1056/NEJMp2025331. Epub 2020 Sep 8.
3
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.单次接种 Ad26 疫苗可预防恒河猴感染 SARS-CoV-2。
Nature. 2020 Oct;586(7830):583-588. doi: 10.1038/s41586-020-2607-z. Epub 2020 Jul 30.
4
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.腺病毒载体新冠疫苗（ChAdOx1 nCoV-19）对严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）的安全性和免疫原性：一项 1/2 期、单盲、随机对照临床试验的初步报告。
Lancet. 2020 Aug 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20.
5
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.mRNA 疫苗对 SARS-CoV-2 的作用-初步报告。
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
6
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.一种基于重组腺病毒 5 型的 COVID-19 疫苗的安全性、耐受性和免疫原性：一项剂量递增、开放标签、非随机、首次人体试验。
Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22.
7
Guillain-Barré Syndrome Associated with SARS-CoV-2.与严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）相关的吉兰-巴雷综合征
N Engl J Med. 2020 Jun 25;382(26):2574-2576. doi: 10.1056/NEJMc2009191. Epub 2020 Apr 17.
8
Developing Covid-19 Vaccines at Pandemic Speed.以大流行速度研发新冠疫苗。
N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.
9
Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic.发作性睡病与大流行性流感疫苗接种：为应对下一次大流行，我们需要了解哪些信息
Pediatr Infect Dis J. 2019 Aug;38(8):873-876. doi: 10.1097/INF.0000000000002398.
10
The biggest pandemic risk? Viral misinformation.最大的疫情风险是什么？病毒相关的错误信息。
Nature. 2018 Oct;562(7727):309. doi: 10.1038/d41586-018-07034-4.
Zotero 插件